Adrian Neilan
Direttore/Membro del Consiglio presso AMJ GLOBAL TECHNOLOGY
Profilo
Adrian Neilan is currently the Executive Chairman at Algaecytes Ltd., the Chief Operations Officer & Investment Director at Deepbridge Capital LLP, and the Director at AMJ Global Technology.
Previously, he worked as the Commercial Director at Trinity College Dublin from 2014 to 2019.
Mr. Neilan graduated from Dublin City University in 2001.
Posizioni attive di Adrian Neilan
Società | Posizione | Inizio |
---|---|---|
AMJ GLOBAL TECHNOLOGY | Direttore/Membro del Consiglio | 26/03/2024 |
Deepbridge Capital LLP
Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Direttore operativo | 01/11/2019 |
Algaecytes Ltd.
Algaecytes Ltd. Pharmaceuticals: MajorHealth Technology Algaecytes Ltd. develops algae derived bioactive ingredients. Its products include omega oils, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha linolenic acid (ALA) and Omega 6 oils arachidonic acid (ARA). The company was founded by Naz Bashir and John Dodd on May 25, 2010 and is headquartered in Sandwich, the United Kingdom. | Presidente | 01/02/2020 |
Precedenti posizioni note di Adrian Neilan
Società | Posizione | Fine |
---|---|---|
Trinity College Dublin | Direttore/Membro del Consiglio | 30/11/2019 |
Formazione di Adrian Neilan
Dublin City University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AMJ GLOBAL TECHNOLOGY | Technology Services |
Aziende private | 2 |
---|---|
Deepbridge Capital LLP
Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Finance |
Algaecytes Ltd.
Algaecytes Ltd. Pharmaceuticals: MajorHealth Technology Algaecytes Ltd. develops algae derived bioactive ingredients. Its products include omega oils, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha linolenic acid (ALA) and Omega 6 oils arachidonic acid (ARA). The company was founded by Naz Bashir and John Dodd on May 25, 2010 and is headquartered in Sandwich, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Adrian Neilan